Data spanning the past 90 days through January 09, 2026 reveals that Armata Pharmaceuticals's three principal insider shareholders consist of Director Inc. Innoviva, (16.37Mn shares), Chief Executive Officer Deborah Birx (217.38K shares), Chief Business Officer Pierre Kyme (10.49K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Inc. Innoviva, | 16,365,969 | 01 Apr, 2022 | |
| Deborah Birx | Chief Executive Officer | 217,377 | 14 Jul, 2025 |
| Pierre Kyme | Chief Business Officer | 10,491 | 25 Apr, 2025 |
| Richard Rychlik | Corporate Controller And Pfo | 10,000 | 18 Mar, 2024 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 10 Jul, 2025 | Deborah Birx | Common Stock | D | 13,637 | $2.27 | 217,377 | D | F |
| 14 Mar, 2025 | Pierre Kyme | - | - | 10,491 | D | |||
| 14 Mar, 2025 | Pierre Kyme | Common Stock | D | 1,027 | $1.95 | 10,491 | D | F |
| 14 Mar, 2024 | Deborah Birx | Common Stock | A | 60,000 | $0.00 | 260,000 | D | A |
| 14 Mar, 2024 | Richard Rychlik | Common Stock | A | 10,000 | $0.00 | 10,000 | D | A |
| 14 Mar, 2024 | Richard Rychlik | - | - | 10,000 | D | |||
| 21 Dec, 2023 | Deborah Birx | Common Stock | A | 200,000 | $0.00 | 200,000 | D | A |
| 31 Mar, 2022 | Inc. Innoviva, | Common Stock | A | 5,385,208 | $5.00 | 16,365,969 | I | P |
| 09 Feb, 2022 | Inc. Innoviva, | - | - | 10,980,761 | I | |||
| 09 Feb, 2022 | Inc. Innoviva, | Common Stock | A | 3,614,792 | $5.00 | 10,980,761 | I | P |
| 29 Oct, 2021 | Inc. Innoviva, | Common Stock | A | 1,212,122 | $3.30 | 7,365,969 | I | P |
| 17 Mar, 2021 | Inc. Innoviva, | Common Stock | A | 4,285,935 | $3.25 | 6,153,847 | I | P |
| 26 Jan, 2021 | Inc. Innoviva, | Common Stock | A | 1,867,912 | $3.25 | 1,867,912 | I | P |
| 27 Mar, 2020 | Inc. Innoviva, | - | - | 8,710,800 | D | |||
| 27 Mar, 2020 | Inc. Innoviva, | Common Stock | A | 7,717,661 | $2.87 | 8,710,800 | D | P |
| 08 Dec, 2017 | Paul C Grint | - | - | 43 | D | |||
| 08 Dec, 2017 | Paul C Grint | Common Stock | A | 599 | $0.62 | 43 | D | A |
| 29 Dec, 2016 | Randal J Kirk | - | - | 376 | I | |||
| 29 Dec, 2016 | Randal J Kirk | Common Stock | D | 20,077 | $0.45 | 344 | I | S |
| 29 Dec, 2016 | Randal J Kirk | - | - | 344 | I |